Heart Test Laboratories Inc. Warrant
HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to expand and improve clinical usefulness. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting… Read more
Market Cap & Net Worth: Heart Test Laboratories Inc. Warrant (HSCSW)
Heart Test Laboratories Inc. Warrant (NASDAQ:HSCSW) has a market capitalization of $685.88 ($685.88) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #39254 globally and #12804 in its home market, demonstrating a -10.75% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Heart Test Laboratories Inc. Warrant's stock price $0.07 by its total outstanding shares 9715 (9.71K).
Heart Test Laboratories Inc. Warrant Market Cap History: 2022 to 2026
Heart Test Laboratories Inc. Warrant's market capitalization history from 2022 to 2026. Data shows change from $2.77K to $685.88 (-34.82% CAGR).
Heart Test Laboratories Inc. Warrant Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Heart Test Laboratories Inc. Warrant's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.16x
Heart Test Laboratories Inc. Warrant's market cap is 0.16 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $2.77K | $14.37K | -$4.83 Million | 0.19x | N/A |
| 2023 | $485.75 | $5.15K | -$6.35 Million | 0.09x | N/A |
| 2024 | $292.42 | $18.60K | -$6.61 Million | 0.02x | N/A |
| 2025 | $681.99 | $4.35K | -$8.77 Million | 0.16x | N/A |
Competitor Companies of HSCSW by Market Capitalization
Companies near Heart Test Laboratories Inc. Warrant in the global market cap rankings as of March 18, 2026.
Key companies related to Heart Test Laboratories Inc. Warrant by market ranking:
- Colas SA (STU:REP): Ranked #39245 globally with a market cap of $216.69K USD ( €211.10K EUR).
- SPARTANNASH (SRJ.SG) (STU:SRJ): Ranked #39246 globally with a market cap of $216.54K USD ( €210.96K EUR).
- RightBridge Ventures Group AB (ST:RIGHTB): Ranked #39255 globally with a market cap of $215.80K USD ( Skr2.42 Million SEK).
- Salona Global Medical Device Corporation (PINK:LNDZF): Ranked #39256 globally with a market cap of $215.78K USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #39245 | Colas SA | STU:REP | $216.69K | €22.36 |
| #39246 | SPARTANNASH (SRJ.SG) | STU:SRJ | $216.54K | €21.80 |
| #39255 | RightBridge Ventures Group AB | ST:RIGHTB | $215.80K | Skr0.01 |
| #39256 | Salona Global Medical Device Corporation | PINK:LNDZF | $215.78K | $0.01 |
Heart Test Laboratories Inc. Warrant Historical Marketcap From 2022 to 2026
Between 2022 and today, Heart Test Laboratories Inc. Warrant's market cap moved from $2.77K to $ 685.88, with a yearly change of -34.82%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $685.88 | +0.57% |
| 2025 | $681.99 | +133.22% |
| 2024 | $292.42 | -39.80% |
| 2023 | $485.75 | -82.47% |
| 2022 | $2.77K | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Heart Test Laboratories Inc. Warrant was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $685.88 USD |
| MoneyControl | $685.88 USD |
| MarketWatch | $685.88 USD |
| marketcap.company | $685.88 USD |
| Reuters | $685.88 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.